breath-actuated, but many require a high inspiratory flow to use (Newell and Hume 2006) . Evidence shows that there is no significant difference between device efficacy in any patient group. Each device can work well if the patient can use it (Dolovich et al 2005) . The most suitable device should be selected for each patient.
The National Institute for Health and Clinical Excellence (NICE) provides guidance on inhaler device selection for children up to 15 years of age (NICE 2000 (NICE , 2002 . However, neither this guidance nor the British Guideline on the Management of Asthma (British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) 2003) provides specific advice on device selection for adults who are unable to use a metered dose inhaler. This results in a confusing number of alternative inhaler devices for clinicians to choose from (Geller 2005) .
There is also little robust evidence to show how this decision-making process should be conducted. A collaboration between the American College of Chest Physicians (ACCP) and the American College of Allergy, Asthma and Immunology (ACAAI) reviewed the guiding principles of inhaler device selection and constructed a list of eight considerations (Dolovich et al 2005) :
In what devices is the desired drug available?
What device is the patient likely to be able to use properly given his or her age and clinical setting?
For which device and drug combination is reimbursement available and which devices are least costly?
Can all types of inhaled drugs prescribed be delivered with the same type of device?
Which devices are most convenient for the patient given the time required for administration and device cleaning?
Is the device portable?
Is the device durable? Does the patient or clinician have any specific device preferences?
Nurses, especially those with accredited asthma training, are increasingly working autonomously in asthma management providing diagnosis and follow-up care (Upton et al 2007) . Consequently they have a professional responsibility to base their practice on the best available evidence. Given the lack of published evidence to guide the selection of inhaler devices for patients with asthma, nurses can be influenced by a broad range of other internal and external factors.
Aim
To identify factors that influenced asthma inhaler device selection in asthma practice nurses trained by Education for Health (previously known as the National Respiratory Training Centre) and the relative importance they placed on these factors in clinical practice.
Method
Two questionnaires were developed following three in-depth interviews with asthma nurse experts and a focus group held with eight practice nurses (all nurses were recruited from the 
TABLE 1
Education for Health database and provided informed verbal consent). The first questionnaire used coded statements to identify factors that influenced trained asthma practice nurses' inhaler device selection. The second questionnaire asked open-ended questions to determine asthma nurses' views on device selection. Questionnaire one Forty-four influences were identified from the focus group and developed into coded statements. Statements were rated on a fivepoint Likert scale from one (strongly disagree) to five (strongly agree). Of these, 16 statements were negatively worded to avoid response sets, whereby the respondent selects the same rating for each item without any real consideration. Statements were arranged in six categories on the questionnaire: patient preference for a device, clinician's personal preference, ability to use the device, cost, guidelines and recommendations, and drug and device availability.
Ambiguities in the questionnaire were resolved by the researchers after it was piloted with 29 trained asthma practice nurses recruited from the Education for Health database. The resulting questionnaire was posted to 1,500 asthma nurses who were randomly selected from the Education for Health database. Respondents were asked to complete the questionnaire based on their usual clinical practice. An anonymous response design was used to reduce social desirability bias, that is the tendency for respondents to reply in a manner they consider socially acceptable and therefore it was not possible to follow up non-responders. Questionnaire two A second piloted questionnaire was sent to a random selection of 300 (20%) of the 1,500 nurses. It included openended questions to examine the use of guidelines, training, placebos and sources of information on inhaler selection. Respondents Respondents had successfully completed the Education for Health diploma in asthma management between 1997 and 2003, and were still working in primary care. Recipients were asked to discard the questionnaire if they had not completed the Education for Health diploma in asthma management. Any questionnaires returned by respondents who did not meet the inclusion criteria were not included in the results. Data analysis Negatively worded questionnaire items were reverse scored before analysis to ensure that the direction of scores for each item was the same. Data for 'disagree' and 'strongly disagree' were combined and referred to as 'disagree'. Data for 'agree' and 'strongly agree' were combined and referred to as 'agree'. Analysis was conducted using Minitab® version 13.31 for Windows®. Descriptive data were given. Free text comments were included to support the data.
Ethical considerations
Formal ethical approval was not necessary because respondents were recruited through the Education for Health student database rather than by virtue of their professional role (National Patient Safety Agency 2008). The principles of good clinical practice were adhered to throughout the study, for example the protocol was subjected to rigorous peer review. Completion of the anonymous questionnaires by respondents implied their consent (Royal College of Nursing 2005). Respondents' confidentiality was assured. The research was conducted in 2003.
Results
A response rate of 38% (573) was obtained for the first questionnaire. Of these, 99% (569) were practice nurses, two described their workplace as 'other', one worked as a practice nurse for NHS Direct and one respondent did not answer this question; 21% (64) More than 90% of respondents agreed that the patient's learning ability and the device that the patient currently used affected which inhaler they prescribed. A high proportion also said that the 'street credibility' of certain inhalers was important when choosing a device for teenagers. Free text comments elaborated on this point: 'Let them [adolescents] have a choice, design and style is very important to them, more likely to use if not embarrassed by device' (Respondent 57).
More than 85% agreed that patient age was an important influence. Less than half of respondents felt that family circumstances influenced device choice. Clinician's personal preference Nurses' attitudes were the second largest influence on device selection (Table 2 ). In this section asthma training had the strongest influence on respondents' choice of inhaler. One commented: '[training made her] aware of different types of inhalers, the different techniques required for using correctly, and which are more suitable for different age groups' (Respondent 15). Ensuring that the patient had the minimum possible number of devices also influenced which device respondents opted for. One explained: 'Busy adults may be more likely to comply with combination rather than separate inhalers' (Respondent 20). The least prevalent influences on device selection in this category were respondents' preference (55% agreed) and the presence of a dose counter on the device; two thirds of respondents had no opinion or disagreed that a dose counter was important. Ability to use the device The ability of the patient to use the device was the third strongest influence (Table 3 ). More than 95% of respondents felt that the device should be easy to use, and should fit in with the patient's lifestyle. One said: '[The patient needs the] ability to use correctly to encourage compliance' (Respondent 36). Poor inspiratory flow should also be taken into account because: '[The patient] may be unable to use certain devices due to low inhalation technique' (Respondent 37). More than 90% of respondents agreed that the device should be easy to carry around, and over half said that the size and shape of the device were not important. Eighty six per cent agreed that the need for a spacer with the device should be considered. Almost one quarter of respondents said that manual dexterity was not important and more than half stated that the number of times a day the inhaler needed to be used did not influence their choice of device. Moreover, about two thirds of respondents said that the patient's job or the colour of the inhaler did not affect their selection. Cost This was as influential in device selection as factors about the patient's ability to use the device (Table 4) . Just under one third of respondents said that they would consider whether patients paid for their prescription when choosing a device. More than 90% said that the cost of the device to the patient was important, but just under two thirds felt that the cost to the TABLE 3 practice or primary care trust (PCT) should be considered when selecting a device. Guidelines and recommendations The influence of these was comparatively low (Table 5) . On average, less than half of respondents agreed with the statements in this category. However, more than 70% agreed that the BTS and SIGN (2003) guideline influenced which inhaler they opted for.
Responses to the open-ended questionnaire indicated that BTS guidelines were important to inhaler device selection as they provided an 'evidence and research-based, nationally recognised, universal approach' (Respondent 23) and were 'current and up to date' (Respondent 2). More than two thirds of respondents said that information from pharmaceutical company representatives, and the preferences of the GPs they worked with influenced their choice of device. Fifty nine per cent felt that information from patient charities was influential. Less than one third said that information from the patient's hospital consultant, British National Formulary (BNF) or Monthly Index of Medical Specialities (MIMS) influenced their choice. A total of 6% of respondents thought that information from the internet affected their selection of an appropriate device. Drug and device availability This was reported to be the least influential category (Table 6 ). Despite this more than one third of respondents indicated that some inhaler devices were not stocked in the local pharmacy. The drug used was the most influential factor (about two thirds agreed) in respondents' choice of inhaler in this section. Fewer than half said they based their choice of inhaler on whether it was available on the practice, PCT or hospital formulary. Eighty per cent of respondents had no opinion or thought it was not important to base their decision on whether they had a placebo device with which to demonstrate technique.
Discussion
Limitations of the study included the anonymous response design, which meant that it was not possible to identify non-responders and follow them up more intensively. This resulted in a moderate response rate, and might mean that the results are not representative among the general practice population. However, the large sample size enables meaningful conclusions to be drawn.
A strength of the study was the random selection of trained asthma nurses working in primary care from the Education for Health database. This ensured a good geographical spread of respondents, allowing for variations in practice size, structure and demographic. Robust methods involving focus groups with asthma nurses trained by Education for Health and clinical asthma concordance. While taking patient preference and satisfaction into account when selecting a device can improve clinical outcomes and is encouraged by the BTS and SIGN (2003) guideline and the ACCP/ACAAI guidelines (Dolovich et al 2005) , an association between concordance and patient preference has not been proven to date (Anderson 2005) .
Practice nurses, especially those with asthma training, are increasingly conducting asthma care autonomously. A recent survey found that 66% of practice nurses are now working at an advanced level, diagnosing and providing follow-up care to asthma patients (Upton et al 2007) .
The study reported here found that respondents were using information from their asthma training and the advice of the BTS and SIGN (2003) guideline to help them make clinical decisions. Eighty six per cent of respondents reported that their asthma training influenced how they chose devices, suggesting that they were using the evidence-based knowledge gained through their training to make informed decisions. Despite the lack of devicespecific advice contained in the BTS and SIGN (2003) guideline, 71% of respondents referred to it when choosing an appropriate inhaler. Specifically, there is no advice in the guideline to suggest how a device should be selected for those adult patients who cannot use a metered dose inhaler (BTS and SIGN 2003) . It does advocate that choice should be based on the drug required by the patient, their ability to use the device, local cost and patient preference. It seems that, although respondents stated that they were following the guideline, they might be 'cherrypicking' which aspects they followed. Forty per cent of respondents had no opinion or disagreed that local cost was important. In the current era of financial constraints in the NHS and with many asthma nurses working autonomously, it is important that nurses understand and consider cost. In spite of advice from the BTS and SIGN (2003) guideline, respondents indicated that they were not doing so. In addition more than one-third of respondents had no opinion or disagreed that their choice of device depended on what drug was used.
Respondents also considered pharmaceutical representatives influential when selecting a device. This is in line with evidence showing that the pharmaceutical industry is able to influence drug and device prescribing at a local and national level via its relationships with clinical staff (Kmietowicz 2004) . Nurses working in these autonomous roles should be aware of these potential influences on their clinical decisions, and ensure that their practice conforms to best evidence where possible.
Interestingly, 41% of respondents did not appear to be influenced by or adhere to decisions TABLE 6 experts were used to develop and design the questionnaires, which were carefully piloted and amended before further dissemination.
The study aimed to identify factors that influence asthma inhaler device selection in trained asthma nurses. Results showed that questions about patient preference consistently received higher scores, with the most important influences being those relating directly to patients. Respondents also reported that the asthma training they had received had a substantial influence on device selection. Less important influences appeared to be those relating to the availability of the device, the size, shape and colour of the inhaler, and recommendations from clinical 'experts', hospital consultants, BNF/MIMS information, and the internet.
Research has shown that control of asthma is based on optimal drug delivery and patient concordance with treatment (Horne et al 2007) . Respondents in the reported study stated that if patients disliked a device or were unable to use it they were unlikely to persevere with treatment, and that they appeared to prioritise patientrelated influences in a bid to improve made by the patient's hospital consultant, which might lead to distrust between primary and secondary care clinicians, and patient confusion. Six per cent of respondents took advice from the internet, most which is unregulated and can be inaccurate (Madoc-Sutton 2007) .
Properties of inhaler devices were associated with other strong influences on device selection. The most important of these were that it was easy to use, fitted in with the patient's lifestyle and was portable. This is unsurprising considering the number of devices on the market and the desire expressed by respondents to find a suitable device for individual patients.
Conclusion
When managing patients with asthma, nurses need to consider a range of factors when selecting a device from the large number available. Until now, there has been no published research on factors that influence asthma inhaler device selection by nurses, and only a small amount that provides practical advice on how to do so. Given that it is unlikely that more effective drugs will be developed in the foreseeable future (Barnes 2004) , device selection will be increasingly important. The ACCP/ACAAI guidelines (Dolovich et al 2005) are useful but the study reported here found that, while trained asthma nurses in the UK are considering some of the points outlined in these guidelines, there is still some way to go. The authors propose developing and testing an algorithm or checklist based on best available evidence to guide device selection in primary care, which could be evaluated for usefulness and applicability. Until then, nurses caring for patients with asthma should be aware of potential influences on device selection and consider their professional accountability in all patient interactions NS
